These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 30072263
1. Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Effects of Antithrombin Versus Placebo on the Coagulation System in Infants with Low Antithrombin Undergoing Congenital Cardiac Surgery. Jooste EH, Scholl R, Wu YH, Jaquiss RDB, Lodge AJ, Ames WA, Homi HM, Machovec KA, Greene NH, Donahue BS, Shah N, Benkwitz C. J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):396-402. PubMed ID: 30072263 [Abstract] [Full Text] [Related]
2. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS. Artif Organs; 2016 Jan; 40(1):80-5. PubMed ID: 26620919 [Abstract] [Full Text] [Related]
8. Is there evidence that fresh frozen plasma is superior to antithrombin administration to treat heparin resistance in cardiac surgery? Beattie GW, Jeffrey RR. Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):117-20. PubMed ID: 24014620 [Abstract] [Full Text] [Related]
9. Surgical treatment of atrial septal defect in a patient with familial antithrombin-III deficiency. Hattori T, Hata M, Sezai A, Wakui S, Shiono M. Ann Thorac Cardiovasc Surg; 2013 Jan; 19(4):323-5. PubMed ID: 23232305 [Abstract] [Full Text] [Related]
15. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy. Paparella D, Parolari A, Rotunno C, Vincent J, Myasoedova V, Guida P, De Palo M, Margari V, Devereaux PJ, Lamy A, Alamanni F, Yusuf S, Whitlock R. Semin Thorac Cardiovasc Surg; 2022 Oct 01; 29(1):35-44. PubMed ID: 28683994 [Abstract] [Full Text] [Related]
16. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J, Peltola K, Sairanen H, Leijala M, Kekomäki R, Vahtera E, Siimes MA. J Thorac Cardiovasc Surg; 1996 Sep 01; 112(3):665-71. PubMed ID: 8800154 [Abstract] [Full Text] [Related]
17. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery. Yamamoto T, Wolf HG, Sinzobahamvya N, Asfour B, Hraska V, Schindler E. Thorac Cardiovasc Surg; 2015 Aug 01; 63(5):397-403. PubMed ID: 26121380 [Abstract] [Full Text] [Related]
18. Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report. Brinks HJ, Weerwind PW, Verkroost MW, Nováková I, Brouwer MH. Perfusion; 2000 Nov 01; 15(6):553-6. PubMed ID: 11131221 [Abstract] [Full Text] [Related]
20. Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency. Nishimura Y, Takagi Y. Ann Thorac Cardiovasc Surg; 2018 Aug 20; 24(4):187-192. PubMed ID: 29681597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]